• NTRK Drug Wins Approval for All Solid Tumors

    One year ago - By MedPageToday

    Second "tissue agnostic" approval from agency
    Read more ...


  • FDA Approves Novel 'Tissue Agnostic' Cancer Drug

    One year ago - By Medscape

    Larotrectinib targets a key genetic driver that occurs in multiple types of cancer, rather than a specific tumor type.
    FDA Approvals
    Read more ...